VE-cadherin
VE-cadherin, also known as vascular endothelial cadherin or CDH5, is a type of cadherin protein that is specifically expressed in endothelial cells. It plays a crucial role in the maintenance and regulation of endothelial cell junctions, which are essential for the integrity and function of the vascular system.
Structure[edit | edit source]
VE-cadherin is a classical cadherin, which means it is a transmembrane protein that mediates cell-cell adhesion through calcium-dependent interactions. The protein consists of five extracellular cadherin repeats, a single transmembrane domain, and a cytoplasmic tail that interacts with the actin cytoskeleton via catenins.
Function[edit | edit source]
VE-cadherin is a key component of adherens junctions in endothelial cells. It is involved in the regulation of vascular permeability and the maintenance of the endothelial barrier. By forming homophilic interactions with VE-cadherin molecules on adjacent cells, it helps to maintain the structural integrity of blood vessels.
Role in Vascular Permeability[edit | edit source]
VE-cadherin is critical in controlling the passage of fluids and solutes across the endothelial barrier. Disruption of VE-cadherin interactions can lead to increased vascular permeability, which is a hallmark of inflammation and is involved in various pathological conditions such as edema and sepsis.
Angiogenesis[edit | edit source]
VE-cadherin is also involved in angiogenesis, the process of new blood vessel formation. It regulates endothelial cell proliferation, migration, and survival, which are essential steps in the formation of new blood vessels.
Clinical Significance[edit | edit source]
Alterations in VE-cadherin expression or function can contribute to various diseases. For example, reduced VE-cadherin expression is associated with increased tumor metastasis due to enhanced vascular permeability. Conversely, overexpression of VE-cadherin can lead to vascular malformations.
Research and Therapeutic Potential[edit | edit source]
VE-cadherin is a target for therapeutic interventions aimed at modulating vascular permeability and angiogenesis. Inhibitors of VE-cadherin function are being explored for their potential to prevent tumor metastasis and to treat diseases characterized by excessive vascular leakage.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD